Cushman & Wakefield (NYSE: CWK) director settles RSUs and gets new grant

Rhea-AI Filing Summary

Cushman & Wakefield Ltd. director Jodie W. McLean reported compensation-related equity activity. On May 15, 2026, previously awarded restricted stock units (RSUs) for 17,013 shares converted into the same number of common shares without any cash payment, leaving her with 88,836 common shares held directly.

Separately, on May 14, 2026, she received a new grant of 14,041 RSUs that will vest and settle into an equal number of common shares on May 14, 2027, subject to her continued board service. These are routine director equity awards and RSU settlements, not open-market share purchases or sales.

Insider Trade Summary

17,013 shares exercised/converted

Mixed 3 txns

Insider McLean Jodie W.

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	17,013	$0.00	--
Exercise	Common Shares	17,013	$0.00	--
Grant/Award	Restricted Stock Units	14,041	$0.00	--

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Shares — 88,836 shares (Direct, null)

Footnotes (1)

1. Conversion of previously awarded restricted stock units ("RSUs") into an equal number of common shares, without the payment of any consideration, pursuant to the Third Amended & Restated 2018 Omnibus Non-Employee Director Share and Cash Incentive Plan. RSUs granted under the Cushman & Wakefield Ltd. 2026 Omnibus Share and Cash Incentive Plan convert into an equal number of common shares of Cushman & Wakefield Ltd. without the payment of any consideration. RSUs were granted on May 14, 2026 and vest and settle on May 14, 2027 subject, with certain limited exceptions, to the reporting person's continuing board service through such vesting date. RSUs were granted on May 15, 2025 and vested and settled on May 15, 2026.

Key Figures

RSUs converted: 17,013 shares Common shares held: 88,836 shares New RSU grant: 14,041 RSUs +2 more

5 metrics

RSUs converted 17,013 shares Previously awarded RSUs converted to common shares on May 15, 2026

Common shares held 88,836 shares Direct holdings after RSU conversion on May 15, 2026

New RSU grant 14,041 RSUs Granted on May 14, 2026; vest and settle on May 14, 2027

Exercise transactions 1 exercise, 17,013 shares Derivative exercise/conversion reported in transaction summary

Acquire transactions 3 transactions All transactions classified as acquisitions in transaction summary

Key Terms

Restricted Stock Units, derivative exercise/conversion, Omnibus Share and Cash Incentive Plan, vest and settle

4 terms

Restricted Stock Units financial

"Restricted Stock Units, transaction_code "M" and "A", underlying security common shares"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

derivative exercise/conversion financial

"transaction_action "derivative exercise/conversion" for RSUs converting into common shares"

Omnibus Share and Cash Incentive Plan financial

"RSUs granted under the Cushman & Wakefield Ltd. 2026 Omnibus Share and Cash Incentive Plan"

vest and settle financial

"RSUs were granted on May 14, 2026 and vest and settle on May 14, 2027"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McLean Jodie W.

(Last) (First) (Middle)

225 WEST WACKER DRIVE

(Street)

CHICAGO ILLINOIS 60606

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cushman & Wakefield Ltd. [ CWK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	05/15/2026		M		17,013	A	(1)	88,836	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	05/14/2026		A		14,041		(3)	(3)	Common Shares	14,041	$0	14,041	D
Restricted Stock Units	(1)	05/15/2026		M			17,013	(4)	(4)	Common Shares	17,013	$0	0	D

Explanation of Responses:

1. Conversion of previously awarded restricted stock units ("RSUs") into an equal number of common shares, without the payment of any consideration, pursuant to the Third Amended & Restated 2018 Omnibus Non-Employee Director Share and Cash Incentive Plan.

2. RSUs granted under the Cushman & Wakefield Ltd. 2026 Omnibus Share and Cash Incentive Plan convert into an equal number of common shares of Cushman & Wakefield Ltd. without the payment of any consideration.

3. RSUs were granted on May 14, 2026 and vest and settle on May 14, 2027 subject, with certain limited exceptions, to the reporting person's continuing board service through such vesting date.

4. RSUs were granted on May 15, 2025 and vested and settled on May 15, 2026.

Remarks:

	/s/ Noelle J. Perkins, attorney-in-fact	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Cushman & Wakefield (CWK) disclose for Jodie W. McLean?

Cushman & Wakefield reported that director Jodie W. McLean had 17,013 previously awarded RSUs convert into common shares and received a new grant of 14,041 RSUs. These transactions reflect equity compensation and RSU settlement rather than open-market buying or selling activity.

How many Cushman & Wakefield (CWK) shares does Jodie W. McLean hold after these Form 4 transactions?

After the RSU conversion on May 15, 2026, Jodie W. McLean directly holds 88,836 common shares of Cushman & Wakefield. This position reflects shares received from previously granted RSUs converting into common stock without any cash consideration being paid to acquire them.

What are the terms of the new RSU grant reported for Cushman & Wakefield (CWK) director Jodie W. McLean?

On May 14, 2026, Jodie W. McLean received 14,041 restricted stock units. According to the disclosure, these RSUs vest and settle into an equal number of common shares on May 14, 2027, provided she continues serving on the board through that vesting date.

Did Cushman & Wakefield (CWK) director Jodie W. McLean buy or sell shares on the open market?

The reported transactions do not show any open-market purchases or sales. Instead, they reflect the automatic conversion of 17,013 previously awarded RSUs into common shares and a new grant of 14,041 RSUs as part of equity compensation arrangements.

How were the Cushman & Wakefield (CWK) RSUs converted into common shares for Jodie W. McLean?

Previously granted RSUs for 17,013 shares converted into an equal number of Cushman & Wakefield common shares without cash payment. The conversion occurred under the company’s non-employee director share and cash incentive plan as part of standard RSU settlement mechanics.